Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Forte Biosciences Inc FBRX

Set alert

Price alert · FBRX

All alert types
76.99 USD 0.00 0.00%

At close · Aug 26

21.03 -55.96 -72.68%

After hours · Aug 26, 4:00 PM ET

Bid
20.86 × 42
Ask
20.91 × 2
76.96 Day range 77.00
10.30 52-week range 77.20
YTD
+182.32%
1 year
+574.76%
Open
76.97
Prev close
76.99
Mkt cap
1.63B
Vol
1.40M
Avg vol
1.86M
EPS
-4.65
P/E
0.00
Div yield
0.00%
More statistics
Low
76.96
High
77.00
Forward P/E
-18.89
Beta
2.65
Short ratio
0.82
Inst. own
96.65%
Dividend
0.00
Ex-div date
Earnings
Nov 13, 2026
50-d avg
55.18
200-d avg
33.25
1y target
73.00

5Y chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-year price history for FBRX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: buy

Buy
Price target (mean) 73.00 -5.2% downside
Target (low)
61.00
Target (mean)
73.00
Target (high)
77.00
Ratings (0m) 4 1 buy · 3 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold3
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 5
  • 2 months ago 5
  • 3 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

FBRX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.09-1.09 – -1.09-0.99-10.1%00.0%1
Next quarter-1.11-1.11 – -1.11-1.45+23.4%00.0%1
Current year-4.48-4.48 – -4.48-4.71+4.9%00.0%1
Next year-4.08-5.91 – -2.89-4.48+9.0%00.0%4

Upgrades and downgrades

The latest rating changes

FBRX analyst upgrades and downgrades
DateFirmActionFromTo
Jul 28, 2026BarclaysDowngradeOverweightEqual-Weight
Jul 21, 2026BarclaysInitiated—Overweight
Nov 25, 2025Evercore ISI GroupInitiated—Outperform
Nov 17, 2025Chardan CapitalMaintainedBuyBuy
Aug 18, 2025GuggenheimInitiated—Buy
Aug 15, 2025Chardan CapitalMaintainedBuyBuy
Jun 24, 2025Chardan CapitalMaintainedBuyBuy
Apr 1, 2025Chardan CapitalMaintainedBuyBuy
Jan 21, 2025TD CowenInitiated—Buy
Dec 4, 2024Chardan CapitalMaintainedBuyBuy
Nov 15, 2024Chardan CapitalMaintainedBuyBuy
Aug 19, 2024Chardan CapitalMaintainedBuyBuy
May 30, 2024Brookline CapitalInitiated—Buy
Apr 8, 2024Ladenburg ThalmannUpgradeNeutralBuy
Sep 20, 2021Chardan CapitalUpgradeSellNeutral
Sep 3, 2021Brookline CapitalDowngradeBuyHold
Sep 3, 2021Chardan CapitalDowngradeBuySell
Sep 3, 2021Ladenburg ThalmannDowngradeBuyNeutral
Sep 3, 2021B. Riley SecuritiesDowngradeBuyNeutral
Sep 3, 2021Truist SecuritiesDowngradeBuyHold
May 14, 2021B. Riley SecuritiesInitiated—Buy
Mar 26, 2021CitigroupInitiated—Buy
Mar 17, 2021Chardan CapitalMaintained—Buy
Sep 24, 2020Chardan CapitalMaintained—Buy
Sep 10, 2020Chardan CapitalMaintained—Buy
Aug 28, 2020Brookline CapitalInitiated—Buy
Aug 28, 2020Chardan CapitalUpgradeNeutralBuy
Aug 25, 2020Truist SecuritiesInitiated—Buy
Jun 22, 2020Ladenburg ThalmannInitiated—Buy